INM logo

InMed Pharmaceuticals (INM) Working Capital

Annual Working Capital

$6.72 M
-$2.61 M-28.01%

June 30, 2024


Summary


Performance

INM Working Capital Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherINMbalance sheetmetrics:

Quarterly Working Capital

$5.84 M
-$873.80 K-13.01%

September 30, 2024


Summary


Performance

INM Quarterly Working Capital Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherINMbalance sheetmetrics:

Working Capital Formula

Working Capital = Current Assets − Current Liabilities

INM Working Capital Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year-28.0%-31.5%
3 y3 years+9.0%-6.9%
5 y5 years-48.1%-27.8%

INM Working Capital Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-year-28.0%+9.0%-49.7%+25.9%
5 y5-year-48.1%+44.9%-58.4%+80.2%
alltimeall time-65.8%+631.1%-70.2%+424.1%

InMed Pharmaceuticals Working Capital History

DateAnnualQuarterly
Sep 2024
-
$5.84 M(-13.0%)
Jun 2024
$6.72 M(-28.0%)
$6.72 M(-21.3%)
Mar 2024
-
$8.54 M(-15.7%)
Dec 2023
-
$10.13 M(+45.6%)
Sep 2023
-
$6.96 M(-25.5%)
Jun 2023
$9.33 M(+48.6%)
$9.33 M(-2.5%)
Mar 2023
-
$9.57 M(-17.6%)
Dec 2022
-
$11.62 M(+40.6%)
Sep 2022
-
$8.26 M(+31.6%)
Jun 2022
$6.28 M(+1.9%)
$6.28 M(+35.3%)
Mar 2022
-
$4.64 M(-41.2%)
Dec 2021
-
$7.89 M(-43.9%)
Sep 2021
-
$14.05 M(+128.0%)
Jun 2021
$6.16 M(+32.9%)
$6.16 M(-32.9%)
Mar 2021
-
$9.18 M(+13.4%)
Dec 2020
-
$8.10 M(+149.7%)
Sep 2020
-
$3.24 M(-30.1%)
Jun 2020
$4.64 M(-64.2%)
$4.64 M(-20.8%)
Mar 2020
-
$5.85 M(-28.6%)
Dec 2019
-
$8.20 M(-20.1%)
Sep 2019
-
$10.27 M(-20.6%)
Jun 2019
$12.94 M(-34.0%)
$12.94 M(-15.4%)
Mar 2019
-
$15.30 M(-8.6%)
Dec 2018
-
$16.75 M(-11.4%)
Sep 2018
-
$18.90 M(-3.6%)
Jun 2018
$19.61 M(+288.0%)
$19.61 M(+89.9%)
Mar 2018
-
$10.33 M(-0.2%)
Dec 2017
-
$10.34 M(+113.7%)
Sep 2017
-
$4.84 M(-4.3%)
Jun 2017
$5.06 M(-1725.0%)
$5.06 M(+148.5%)
Mar 2017
-
$2.03 M(+343.1%)
Dec 2016
-
$459.10 K(-622.9%)
Sep 2016
-
-$87.80 K(-71.8%)
Jun 2016
-$311.10 K(-323.0%)
-$311.10 K(-44.8%)
Mar 2016
-
-$563.20 K(+109.8%)
Dec 2015
-
-$268.40 K(+136.3%)
Sep 2015
-
-$113.60 K(-181.4%)
Jun 2015
$139.50 K(+20.7%)
$139.50 K(-160.4%)
Mar 2015
-
-$230.80 K(-34.6%)
Dec 2014
-
-$353.00 K(+561.0%)
Sep 2014
-
-$53.40 K(-146.2%)
Jun 2014
$115.60 K(-362.1%)
$115.60 K(-164.8%)
Mar 2014
-
-$178.50 K(+99.4%)
Dec 2013
-
-$89.50 K(+59.8%)
Sep 2013
-
-$56.00 K(+27.0%)
Jun 2013
-$44.10 K
-$44.10 K(+107.0%)
Mar 2013
-
-$21.30 K(+52.1%)
DateAnnualQuarterly
Dec 2012
-
-$14.00 K(-30.3%)
Sep 2012
-
-$20.10 K(-844.4%)
Jun 2012
$2700.00(-98.7%)
$2700.00(-97.4%)
Mar 2012
-
$104.90 K(-15.8%)
Dec 2011
-
$124.60 K(-16.1%)
Sep 2011
-
$148.50 K(-26.6%)
Jun 2011
$202.30 K(-116.0%)
$202.30 K(+41.7%)
Mar 2011
-
$142.80 K(-110.4%)
Dec 2010
-
-$1.38 M(+4.0%)
Sep 2010
-
-$1.32 M(+4.6%)
Jun 2010
-$1.26 M(+22.6%)
-$1.26 M(-13.2%)
Mar 2010
-
-$1.46 M(+9.5%)
Dec 2009
-
-$1.33 M(+9.1%)
Sep 2009
-
-$1.22 M(+18.3%)
Jun 2009
-$1.03 M(+13.7%)
-$1.03 M(-10.6%)
Mar 2009
-
-$1.15 M(+2.7%)
Dec 2008
-
-$1.12 M(+5.3%)
Sep 2008
-
-$1.07 M(+17.5%)
Jun 2008
-$907.80 K(-4.7%)
-$907.80 K(+5.1%)
Mar 2008
-
-$863.90 K(-11.3%)
Dec 2007
-
-$974.10 K(+23.0%)
Sep 2007
-
-$791.80 K(-16.8%)
Jun 2007
-$952.10 K(+48.8%)
-$952.10 K(+113.2%)
Mar 2007
-
-$446.60 K(-43.8%)
Dec 2006
-
-$795.30 K(+106.8%)
Sep 2006
-
-$384.50 K(-39.9%)
Jun 2006
-$639.90 K(-31.0%)
-$639.90 K(-15.8%)
Mar 2006
-
-$760.00 K(+12.4%)
Dec 2005
-
-$676.10 K(-39.3%)
Sep 2005
-
-$1.11 M(+20.0%)
Jun 2005
-$927.80 K(+84.1%)
-$927.80 K(+222.0%)
Mar 2005
-
-$288.10 K(-84.0%)
Dec 2004
-
-$1.80 M(+246.9%)
Sep 2004
-
-$519.90 K(+3.2%)
Jul 2004
-$503.90 K(+822.9%)
-$503.90 K(+83.2%)
Apr 2004
-
-$275.00 K(-44.0%)
Jan 2004
-
-$491.50 K(+112.7%)
Oct 2003
-
-$231.10 K(+323.3%)
Jul 2003
-$54.60 K(-105.8%)
-$54.60 K(-109.9%)
Apr 2003
-
$549.40 K(-16.9%)
Jan 2003
-
$660.90 K(-17.7%)
Oct 2002
-
$803.10 K(-15.0%)
Jul 2002
$944.80 K(-49.7%)
$944.80 K(-15.9%)
Apr 2002
-
$1.12 M(-14.7%)
Jan 2002
-
$1.32 M(-15.4%)
Oct 2001
-
$1.56 M
Jul 2001
$1.88 M
-

FAQ

  • What is InMed Pharmaceuticals annual working capital?
  • What is the all time high annual working capital for InMed Pharmaceuticals?
  • What is InMed Pharmaceuticals annual working capital year-on-year change?
  • What is InMed Pharmaceuticals quarterly working capital?
  • What is the all time high quarterly working capital for InMed Pharmaceuticals?
  • What is InMed Pharmaceuticals quarterly working capital year-on-year change?

What is InMed Pharmaceuticals annual working capital?

The current annual working capital of INM is $6.72 M

What is the all time high annual working capital for InMed Pharmaceuticals?

InMed Pharmaceuticals all-time high annual working capital is $19.61 M

What is InMed Pharmaceuticals annual working capital year-on-year change?

Over the past year, INM annual working capital has changed by -$2.61 M (-28.01%)

What is InMed Pharmaceuticals quarterly working capital?

The current quarterly working capital of INM is $5.84 M

What is the all time high quarterly working capital for InMed Pharmaceuticals?

InMed Pharmaceuticals all-time high quarterly working capital is $19.61 M

What is InMed Pharmaceuticals quarterly working capital year-on-year change?

Over the past year, INM quarterly working capital has changed by -$2.69 M (-31.53%)